Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Clinical trial NCT03392974 · COMPLETED
Trial details
- NCT number
- NCT03392974
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-14
- Primary completion
- 2019-05-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.